Manufacturing / Biological Products, Except Diagnostic Substances
RECURSION PHARMACEUTICALS, INC.
RXRX
$4.36
+$0.41 (+10.38%)
Price as of Oct 9, 2026 22:47 UTC
1.7 B
Market Cap (Small Cap)
23%
IV Rank
99.2%
Implied Volatility
Nov 03
Next Earnings
Technical Signals
as of Oct 7
Mixed
4 of 7
Trend
- Above 20-day average $3.96
- Above 50-day average $3.65
- Above 200-day average $3.81 · +12.1%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) 30d ago
Volume
- Elevated volume 1.6x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.21
Bullish skew
Implied Volatility
99.2%
1% percentile
IV vs Realized
Options rich
30d HV 91.4%
Options Heat Map
Delta-risk grid for RXRX options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
43 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Oct 06, 2026 | HERSHBERG ROBERT | Exercise | 25,000 | $55,500 | +77.9% | |
| Oct 06, 2026 | HERSHBERG ROBERT | Exercise | 25,000 | $55,500 | +77.9% | |
| Oct 06, 2026 | HERSHBERG ROBERT | Sell | 25,000 | $125,000 | -21.0% | |
| Oct 06, 2026 | Borgeson Blake | Sell | 50,000 | $242,000 | -18.4% | |
| Oct 01, 2026 | Dar Zavain | Grant | 4,607 | $0 | -2.9% | |
| Oct 01, 2026 | Li Dean Y | Grant | 3,378 | $0 | -2.9% | |
| Sep 15, 2026 | Taylor Ben R | Tax_withholding | 5,396 | $18,400 | +15.8% | |
| Sep 08, 2026 | Khan Najat | Sell | 22,408 | $78,822 | +12.3% | |
| Sep 01, 2026 | Borgeson Blake | Sell | 30,000 | $100,200 | +18.3% | |
| Aug 17, 2026 | Khan Najat | Tax_withholding | 80,498 | $254,374 | +25.0% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 11, 2026 | Q2 2026 | -$0.24 | |||
| Aug 05, 2026 | Q2 2026 | -$0.24 | |||
| Aug 03, 2026 | Q2 2026 | -$0.24 | |||
| Jun 30, 2026 | Q2 2026 | -$0.24 | -$0.25 | -4.7% | Miss |
| Mar 31, 2026 | Q1 2026 | -$0.28 | -$0.22 | +20.5% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.32 | -$0.21 | +34.8% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.38 | -$0.36 | +4.6% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.36 | -$0.41 | -14.8% | Miss |
Track RXRX with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for RXRX and your entire portfolio.